Boule Diagnostics Q3 2026 swings to tax loss, expects higher sales

Boule Diagnostics reported a Q3 2026 tax loss of SEK 2.5M, down from a profit of SEK 10.9M a year earlier, yet the company expects higher sales. The loss may reflect one-off items or investment, but the sales outlook suggests underlying demand remains intact. This is a company-specific earnings update with limited macro impact.

AI disclosure: Model-written summary of the source, not a verified fact. Check the sources. How Mosaic works